Duvakitug Meets Primary Endpoints in Phase 2b RELIEVE UCCD Study for IBD

Published Date: 19 Dec 2024

Duvakitug Meets Primary Endpoints in Phase 2b RELIEVE UCCD Study for IBD

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".

2.

Schizophrenia patients are motivated by music therapy.

3.

Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?

4.

Indoor hydroponic gardening can improve mental health and quality of life for cancer patients

5.

De-escalation Misses the Mark in Inflammatory Breast Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot